Anticoagulation therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Femoral Vein Mesenteric Veins Atrial Appendage Iliac Vein Vena Cava, Inferior Leg Portal Vein Subclavian Vein Aortic Valve Axillary Vein Mitral Valve Heart Atria

Diseases40

Venous Thrombosis Thromboembolism Atrial Fibrillation Hemorrhage Pulmonary Embolism Thrombosis Venous Thromboembolism Hematoma Stroke Embolism Antiphospholipid Syndrome Postthrombotic Syndrome Sinus Thrombosis, Intracranial Thrombophlebitis Recurrence Heart Valve Diseases Postoperative Complications Acute Disease Thrombophilia Intracranial Hemorrhages Blood Coagulation Disorders Cerebral Hemorrhage Coronary Thrombosis Heart Diseases Intracranial Embolism and Thrombosis Thrombocytopenia Postoperative Hemorrhage Cerebrovascular Disorders Intracranial Embolism Pregnancy Complications, Cardiovascular Intracranial Thrombosis Postphlebitic Syndrome Sagittal Sinus Thrombosis Mesenteric Vascular Occlusion Brain Ischemia Disseminated Intravascular Coagulation Antithrombin III Deficiency Ischemic Attack, Transient Endocarditis Heart Valve Prolapse

Chemicals and Drugs43

Anticoagulants Warfarin beta-Alanine Phenprocoumon Acenocoumarol Heparin Heparin, Low-Molecular-Weight Aspirin Vitamin K Benzimidazoles Platelet Aggregation Inhibitors Antithrombins Fibrinolytic Agents Heparin Antagonists Enoxaparin Fibrin Fibrinogen Degradation Products Vitamin K Epoxide Reductases Pipecolic Acids Hirudins Citric Acid Protamines Factor Xa Heparinoids Dalteparin Blood Coagulation Factors Coumarins 4-Hydroxycoumarins Prothrombin Coagulants Phenindione Ticlopidine Thiophenes Citrates Antithrombin III Pyridones Nadroparin Ancrod Diatomaceous Earth Protein C Antifibrinolytic Agents Aryl Hydrocarbon Hydroxylases Factor V Mixed Function Oxygenases

Analytical, Diagnostic and Therapeutic Techniques and Equipment52

International Normalized Ratio Vena Cava Filters Prothrombin Time Administration, Oral Drug Monitoring Treatment Outcome Heart Valve Prosthesis Echocardiography, Transesophageal Retrospective Studies Follow-Up Studies Risk Factors Whole Blood Coagulation Time Blood Coagulation Tests Phlebography Thrombolytic Therapy Prospective Studies Thrombectomy Tomography, X-Ray Computed Risk Assessment Partial Thromboplastin Time Drug Therapy, Combination Stents Incidence Hemofiltration Cohort Studies Electric Countershock Drug Dosage Calculations Hirudin Therapy Hemostatic Techniques Drug Substitution Heart Valve Prosthesis Implantation Bioprosthesis Drug Administration Schedule Premedication Perioperative Care Hemodiafiltration Clinical Protocols Renal Dialysis Embolectomy Catheterization, Peripheral Ultrasonography, Doppler, Duplex Extracorporeal Circulation Withholding Treatment Heart-Assist Devices Randomized Controlled Trials as Topic Catheter Ablation Drug Therapy, Computer-Assisted Ambulatory Care Cardiopulmonary Bypass Patient Selection Prosthesis Design Extracorporeal Membrane Oxygenation

Phenomena and Processes7

Prothrombin Time Blood Coagulation Whole Blood Coagulation Time Time Factors Partial Thromboplastin Time Hemostasis Dose-Response Relationship, Drug

Disciplines and Occupations2

Pharmacogenetics Evidence-Based Medicine

Information Science2

Incidence Drug Therapy, Computer-Assisted

Health Care22

Treatment Outcome Retrospective Studies Follow-Up Studies Risk Factors Prospective Studies Risk Assessment Practice Guidelines as Topic Incidence Cohort Studies Point-of-Care Systems Nursing Services Drug Substitution Perioperative Care Ambulatory Care Facilities Clinical Protocols Cost Allocation Withholding Treatment Randomized Controlled Trials as Topic Medication Therapy Management Ambulatory Care Patient Selection Hospitals, Veterans

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Anticoagulants Warfarin International Normalized Ratio Venous Thrombosis Thromboembolism Atrial Fibrillation beta-Alanine Hemorrhage Pulmonary Embolism Vena Cava Filters Prothrombin Time Thrombosis Phenprocoumon Acenocoumarol Heparin Heparin, Low-Molecular-Weight Administration, Oral Venous Thromboembolism Drug Monitoring Treatment Outcome Heart Valve Prosthesis Hematoma Stroke Embolism Aspirin Vitamin K Femoral Vein Echocardiography, Transesophageal Blood Coagulation Benzimidazoles Platelet Aggregation Inhibitors Antiphospholipid Syndrome Postthrombotic Syndrome Antithrombins Fibrinolytic Agents Mesenteric Veins Atrial Appendage Sinus Thrombosis, Intracranial Thrombophlebitis Retrospective Studies Follow-Up Studies Risk Factors Whole Blood Coagulation Time Recurrence Blood Coagulation Tests Iliac Vein Phlebography Thrombolytic Therapy Prospective Studies Heart Valve Diseases Time Factors Vena Cava, Inferior Thrombectomy Tomography, X-Ray Computed Leg Heparin Antagonists Portal Vein Risk Assessment Postoperative Complications Practice Guidelines as Topic Partial Thromboplastin Time Drug Therapy, Combination Stents Incidence Acute Disease Hemofiltration Enoxaparin Cohort Studies Fibrin Fibrinogen Degradation Products Vitamin K Epoxide Reductases Thrombophilia Intracranial Hemorrhages Pipecolic Acids Hirudins Citric Acid Protamines Blood Coagulation Disorders Cerebral Hemorrhage Electric Countershock Factor Xa Heparinoids Point-of-Care Systems Dalteparin Drug Dosage Calculations Hirudin Therapy Nursing Services Blood Coagulation Factors Hemostatic Techniques Coronary Thrombosis Coumarins Drug Substitution Heart Diseases 4-Hydroxycoumarins Intracranial Embolism and Thrombosis Prothrombin Hemostasis Heart Valve Prosthesis Implantation Thrombocytopenia Postoperative Hemorrhage Bioprosthesis

No FAQ available that match "anticoagulation therapy"